Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Zist Daru, ZIFERON
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.
Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with MS.
Parenteral Dilantin®
International Society for Neurovascular Disease (ISNVD)
Mycophenolate mofetil therapy in the management of inflammatory bowel disease - A retrospective case series and review.
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
Episode 53: Part 1 with Dr. Jonathan Kipnis on the discovery of lymphatic vessels in the meninges
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
Invitation to Share Your Thoughts on a New MS Research Resource
12th International Society of Neuroimmunology Congress
Episode 45 with Dr. Simon Hametner on the role of iron in MS
Episode 54 with Dr. Jonathan Kipnis: Part 2 on meningeal lymphatic vessels in neuroinflammation, and clinical implications
Episode 58 with Dr. Gavin Giovannoni on the new MS Brain Health initiative
EAE: an immunologist's magic eye.
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study.
Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
Episode 41 with Dr. Diego Cadavid on a clinical trial of anti-LINGO-1
Recruiting women smokers: the engineering of consent.
EMD Serono Joins ACP to Launch OPT-UP Study
FOCIS 2014: Spotlight on Translational Immunology
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
Mycophenolate mofetil in the treatment of multiple sclerosis: A preliminary report.
Neurodegeneration: From Multiple Sclerosis to Alzheimer’s Disease
Pages
« first
‹ previous
…
47
48
49
50
51
52
53
54
55
…
next ›
last »